Implanet SA (ALIMP) - Net Assets
Based on the latest financial reports, Implanet SA (ALIMP) has net assets worth €404.00K EUR (≈ $472.32K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€18.45 Million ≈ $21.57 Million USD) and total liabilities (€18.04 Million ≈ $21.09 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALIMP goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €404.00K |
| % of Total Assets | 2.19% |
| Annual Growth Rate | -17.26% |
| 5-Year Change | -85.59% |
| 10-Year Change | -95.82% |
| Growth Volatility | 83.01 |
Implanet SA - Net Assets Trend (2010–2025)
This chart illustrates how Implanet SA's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Implanet SA to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Implanet SA (2010–2025)
The table below shows the annual net assets of Implanet SA from 2010 to 2025. For live valuation and market cap data, see how much is Implanet SA worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €404.00K ≈ $472.32K |
-44.43% |
| 2024-12-31 | €727.00K ≈ $849.94K |
+517.82% |
| 2023-12-31 | €-174.00K ≈ $-203.42K |
-104.91% |
| 2022-12-31 | €3.54 Million ≈ $4.14 Million |
+26.28% |
| 2021-12-31 | €2.80 Million ≈ $3.28 Million |
+174.36% |
| 2020-12-31 | €1.02 Million ≈ $1.19 Million |
-28.83% |
| 2019-12-31 | €1.44 Million ≈ $1.68 Million |
-40.24% |
| 2018-12-31 | €2.40 Million ≈ $2.81 Million |
-61.78% |
| 2017-12-31 | €6.29 Million ≈ $7.35 Million |
-34.91% |
| 2016-12-31 | €9.66 Million ≈ $11.29 Million |
-0.67% |
| 2015-12-31 | €9.73 Million ≈ $11.37 Million |
+34.81% |
| 2014-12-31 | €7.21 Million ≈ $8.43 Million |
-47.98% |
| 2013-12-31 | €13.87 Million ≈ $16.21 Million |
+196.37% |
| 2012-12-31 | €4.68 Million ≈ $5.47 Million |
-47.18% |
| 2011-12-31 | €8.86 Million ≈ $10.36 Million |
+27.78% |
| 2010-12-31 | €6.93 Million ≈ $8.11 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Implanet SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 438200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €1.44 Million | 355.94% |
| Other Components | €3.35 Million | 828.71% |
| Total Equity | €404.00K | 100.00% |
Implanet SA Competitors by Market Cap
The table below lists competitors of Implanet SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
$28.17 Million |
|
Seoam Machinery Industry Co.Ltd
KQ:100660
|
$28.18 Million |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
$28.18 Million |
|
Perusahaan Sadur Timah Malaysia Perstima Bhd
KLSE:5436
|
$28.20 Million |
|
Orient Precision Industries Inc
KQ:065500
|
$28.14 Million |
|
Micro Digital Co. Ltd
KQ:305090
|
$28.14 Million |
|
WOOJUNG BIO Inc
KQ:215380
|
$28.13 Million |
|
Aware Inc
NASDAQ:AWRE
|
$28.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Implanet SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 727,000 to 404,000, a change of -323,000 (-44.4%).
- Net loss of 4,382,000 reduced equity.
- New share issuances of 4,492,000 increased equity.
- Other comprehensive income increased equity by 185,000.
- Other factors decreased equity by 618,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-4.38 Million | -1084.65% |
| Share Issuances | €4.49 Million | +1111.88% |
| Other Comprehensive Income | €185.00K | +45.79% |
| Other Changes | €-618.00K | -152.97% |
| Total Change | €- | -44.43% |
Book Value vs Market Value Analysis
This analysis compares Implanet SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 65.79x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.01x to 65.79x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €34.81 | €0.19 | x |
| 2013-12-31 | €173.54 | €0.19 | x |
| 2014-12-31 | €53.44 | €0.19 | x |
| 2015-12-31 | €40.14 | €0.19 | x |
| 2016-12-31 | €20.84 | €0.19 | x |
| 2017-12-31 | €10.81 | €0.19 | x |
| 2018-12-31 | €3.22 | €0.19 | x |
| 2019-12-31 | €1.21 | €0.19 | x |
| 2020-12-31 | €0.33 | €0.19 | x |
| 2021-12-31 | €0.33 | €0.19 | x |
| 2022-12-31 | €0.17 | €0.19 | x |
| 2023-12-31 | €0.00 | €0.19 | x |
| 2024-12-31 | €0.01 | €0.19 | x |
| 2025-12-31 | €0.00 | €0.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Implanet SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1084.65%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -35.13%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 45.66x
- Recent ROE (-1084.65%) is below the historical average (-237.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -91.39% | -64.34% | 0.56x | 2.52x | €-4.74 Million |
| 2013 | -49.35% | -102.29% | 0.28x | 1.73x | €-8.23 Million |
| 2014 | -95.25% | -97.63% | 0.48x | 2.02x | €-7.59 Million |
| 2015 | -82.33% | -120.35% | 0.41x | 1.67x | €-8.98 Million |
| 2016 | -75.45% | -93.14% | 0.48x | 1.70x | €-8.25 Million |
| 2017 | -105.15% | -84.33% | 0.62x | 2.00x | €-7.24 Million |
| 2018 | -231.00% | -82.60% | 0.76x | 3.68x | €-5.79 Million |
| 2019 | -253.83% | -49.21% | 0.77x | 6.72x | €-3.79 Million |
| 2020 | -389.04% | -102.16% | 0.45x | 8.51x | €-4.08 Million |
| 2021 | -164.37% | -75.07% | 0.37x | 5.96x | €-4.89 Million |
| 2022 | -99.97% | -44.10% | 0.55x | 4.09x | €-3.89 Million |
| 2023 | 0.00% | -89.65% | 0.70x | 0.00x | €-6.66 Million |
| 2024 | -600.55% | -46.42% | 0.63x | 20.48x | €-4.44 Million |
| 2025 | -1084.65% | -35.13% | 0.68x | 45.66x | €-4.42 Million |
Industry Comparison
This section compares Implanet SA's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $21,536,406
- Average return on equity (ROE) among peers: -156.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Implanet SA (ALIMP) | €404.00K | -91.39% | 44.66x | $28.16 Million |
| Affluent Medical SAS (AFME) | $31.47 Million | -49.74% | 0.80x | $110.43 Million |
| Biosynex (ALBIO) | $66.29 Million | 47.32% | 0.90x | $15.74 Million |
| Bluelinea SA (ALBLU) | $2.68 Million | -60.39% | 3.04x | $9.00 Million |
| Carmat (ALCAR) | $1.40 Million | -1250.42% | 5.16x | $6.37 Million |
| Diagnostic Medical Systems SA (ALDMS) | $25.27 Million | -10.60% | 0.84x | $34.47 Million |
| Eurobio Scientific SA (ALERS) | $18.07 Million | -40.63% | 1.08x | $236.10 Million |
| Ikonisys SA (ALIKO) | $15.73 Million | -14.41% | 0.33x | $21.30 Million |
| Mediantechn (ALMDT) | $-7.25 Million | 0.00% | 0.00x | $183.29 Million |
| Mauna Kea Technologies SAS (ALMKT) | $40.16 Million | -32.51% | 0.22x | $28.43 Million |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more